Navigation Links
New Report by BioTrends Examines the Treatment of Renal Anemia in China
Date:10/6/2010

EXTON, Pa., Oct. 6 /PRNewswire/ -- BioTrends Research Group, Inc. recently published its TreatmentTrends®: Renal Anemia in China report. This report is based on survey results from 150 nephrologists in clinical practice in China and qualitative interviews conducted with ten thought leaders in nephrology.  The report examines the demographics of nephrology practice in China and focuses specifically on the management of renal anemia amongst dialysis and later stage chronic kidney disease (CKD) patients.

Earlier diagnosis of renal insufficiency is leading to a rapid increase in the number of patients being seen by nephrologists, however there were numerous mentions about the disparity of care across regions.  Although the majority of nephrologists suggested that economics were not an impediment to treatment with erythropoietin (EPO) products, only about one-third of those surveyed felt that renal anemia management was optimal in China.  Further, 86 percent of those surveyed agreed that the treatment of anemia should begin earlier in CKD than it does in current clinical practice.  The current EPO market is dominated by short acting EPO agents manufactured by local companies, but more than 70 percent report that an EPO agent with a longer dose interval would be highly desirable in a new EPO product. In fact, 44 percent of the surveyed nephrologists reported that there is a high need for new EPO products and that this need is greater than the unmet need for other therapies such as agents for acute renal failure, hyperphosphatemia and lupus nephritis.

The use of intravenous iron products is also prevalent amongst hemodialysis patients, although the use of oral iron (alone or in combination with i.v. iron) is higher in China as compared to other markets.  Similar to the US and EU markets, surveyed nephrologists report prescribing a low dose, consistent maintenance course of iron in hemodialysis patients as opposed to high dose, infrequent repletion therapy.  Iron sucrose (brand name: Venofer) was noted as the market share leader in both the dialysis and CKD (non-dialysis) settings and the respondents reported very high satisfaction with this agent compared to other brands.  The perceived need for new i.v. iron products was rated significantly lower than the need for new EPO agents.

About BioTrends Research Group, Inc.BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.   For information on BioTrends publications and research capabilities, please contact us at (610) 363-3872 or www.bio-trends.com.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks of their respective holders.For more information, contact:BioTrends Research Group, Inc.Decision Resources, Inc.Sharon Funk

Christopher Comfort404-223-2963

781-993-2597 sfunk@bio-trends.com

ccomfort@dresources.com
'/>"/>

SOURCE BioTrends Research Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthcare Providers Rate Elektas MOSAIQ Oncology Information System as No. 1 in 2010 KLAS Report
2. ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
3. Gerresheimer Reports Strong Earnings and Sales Growth
4. Reportlinker Adds Global Vertebral Compression Fracture Devices Industry
5. Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies
6. Reportlinker Adds US Pharmaceutical Market Overview - Healthcare reform, economic pressures and the patent cliff set to impact Pharma
7. Reportlinker Adds Antidiabetics Market Forecast
8. Reportlinker Adds Global Anti-CD20 Monoclonal Antibodies Industry
9. Reportlinker Adds Global Intravenous (IV) Iron Drugs Industry
10. Reportlinker Adds Global Sleeping Pills Industry
11. Reportlinker Adds Global Immunoassay Systems Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... N.Y. , Dec. 6, 2016  Licenders is bringing their ... This new location in Park Slope at 203 13 th ... Brooklyn clientele. "Our goal is to ... treatment plans are designed to get children right back to class ... are 100% all natural and safe for the whole family," Licenders ...
(Date:12/6/2016)... Dec. 6, 2016  Alopexx Oncology, LLC announced data ... antibody fusion protein (immunocytokine) composed of interleukin-2 and a ... target on B cells as Rituxan and maintains the ... is also involved in tumor targeting, engagement of the ... The results of the study (abstract #95954) were presented ...
(Date:12/6/2016)... 2016  "Blood Tests replace Surgical Biopsies. Single ... The Diagnostic, Monitoring and Screening Test opportunities are ... occurring using in vitro blood testing to identify ... backing, has announced a single blood test to ... than the market. New technology that definitively identifies ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... The medical profession is well aware that ... One major study analyzing heart attacks among 138,602 people recorded a 35% higher number ... We would all agree of course–no time of year is a good time for ...
(Date:12/7/2016)... ... ... "ProBrand Flip allows FCPX editors to create unique logo reveals which can ... Film Studios. , ProBrand Flip includes 30 flip book reveal animations. Easily reveal any ... variety of flip book animations. In Addition, users can modify each preset to fit ...
(Date:12/7/2016)... CINCINNATI, Ohio (PRWEB) , ... December 07, 2016 ... ... winner in the 2016 BOC Business Brilliance Awards under the Best New Product ... inception and results achieved through user experience. , BOC Global Events & Training ...
(Date:12/7/2016)... Scottsdale, AZ (PRWEB) , ... ... ... pioneer, ElectroMedical Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus ... , WellnessPro Plus substantially enhances the WellnessPro platform by expanding the treatment ...
(Date:12/7/2016)... ... 2016 , ... Maureen McLaughlin, LA.c., a certified acupuncturist, is ... Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility patients to ... their family building goals. Acupuncture helps fertility patients by supporting the ...
Breaking Medicine News(10 mins):